tiprankstipranks
ALX Oncology Holdings (ALXO)
NASDAQ:ALXO
US Market
ALXO
ALX Oncology Holdings
RESEARCH TOOLSreports
Want to see ALXO full AI Analyst Report?

ALX Oncology Holdings (ALXO) Financial Statements

443 Followers

ALX Oncology Holdings Financial Overview

ALX Oncology Holdings's market cap is currently $275.06M. The company's EPS TTM is $-1.9; its P/E ratio is -0.67; ALX Oncology Holdings is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -872.00K$ -836.00K$ 0.00$ -736.00K
Operating Income$ -100.85M$ -142.47M$ -170.28M$ -127.44M$ -83.56M
EBITDA$ -100.85M$ -132.25M$ -158.40M$ -122.84M$ -83.42M
Net Income$ -101.69M$ -134.85M$ -160.81M$ -123.48M$ -83.46M
Balance Sheet
Cash & Short-Term Investments$ 44.79M$ 127.76M$ 182.74M$ 266.21M$ 363.67M
Total Assets$ 59.05M$ 147.78M$ 242.55M$ 306.49M$ 380.18M
Total Debt$ 5.22M$ 16.98M$ 17.20M$ 10.43M$ 742.00K
Net Debt$ -11.16M$ -589.00K$ -5.21M$ -38.39M$ -362.93M
Total Liabilities$ 33.06M$ 34.16M$ 52.84M$ 43.02M$ 17.13M
Stockholders' Equity$ 25.98M$ 113.62M$ 189.71M$ 263.46M$ 363.05M
Cash Flow
Free Cash Flow$ -84.35M$ -122.36M$ -131.64M$ -90.65M$ -73.02M
Operating Cash Flow$ -84.14M$ -121.91M$ -130.36M$ -89.22M$ -68.10M
Investing Cash Flow$ 82.59M$ 86.26M$ 44.66M$ -235.42M$ -4.92M
Financing Cash Flow$ 362.00K$ 30.82M$ 59.29M$ 9.86M$ 2.47M
Currency in USD

ALX Oncology Holdings Earnings and Revenue History

Income Statement >

ALX Oncology Holdings Debt to Assets

Balance Sheet >

ALX Oncology Holdings Cash Flow

Cash Flow >

ALX Oncology Holdings Forecast EPS vs Actual EPS

Earnings >